Harvard Portrait: Amy Wagers

The skydiving Forst Family professor studies the pathophysiology of aging.

Amy Wagers

Photograph by Jon Chase/Harvard Public Affairs and Communications

As a 10-year-old, Amy Wagers knew she wanted to be a scientist, but it wasn’t until she registered as a bone-marrow donor during her senior year at Northwestern University that she decided to focus on stem cells. After receiving her Ph.D. in immunology and microbial pathogenesis from Northwestern, and completing a postdoctoral fellowship at Stanford with Irving Weismann, one of the earliest pioneers of stem-cell research, she became an associate professor of pathology and investigator at the Harvard-affiliated Joslin Diabetes Center. “I got into aging through the lens of stem-cell regulation,” she says. “There’s a linkage between the pathophysiology of aging and the pathophysiology of diabetes, particularly type 2 diabetes.” In 2008, Wagers moved to the new department of stem cell and regenerative biology, which she now co-chairs. “When I was a postdoc and I was applying for jobs in academia, my dad said, ‘When are you going to get out of school?’ and I said, ‘Well, hopefully never!’” If she isn’t working with students in her lab, the Forst Family professor of stem cell and regenerative biology is often found spending time with her six-year-old son, teaching or meeting with undergraduates enrolled in her course on aging—or sky-diving above Newport, Rhode Island. That practice unexpectedly became tradition when Wagers promised a colleague that if the very first paper out of her lab was published by the prestigious journal Nature, she would go skydiving to celebrate. “I was so exhilarated! Afterwards, I went to a little clam shack and had a beer and some fried clam strips and I was like, ‘I’m alive!’” Now Wagers invites graduate students whose work is accepted by high-impact publications to join her on a skydiving trip. So far, just one has accepted. 

Read more articles by Oset Babür

You might also like

Lawrence Summers

Previously undisclosed Epstein links to Harvard affiliates leads to a University review.

FAS Cuts Science Ph.D. Admissions By Half

Backing off plans for more drastic reductions, the division still faces a long-term deficit.

Harvard Divinity School Sets New Priorities

After two years of turmoil, Dean Marla Frederick describes a more pluralistic future for the institution’s culture and curriculum.

Most popular

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

The Life of a Harvard Spy

Richard Skeffington Welch’s illustrious—and clandestine—career in the CIA

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.

Explore More From Current Issue

Wolfram Schlenker wearing a suit sitting outdoors, smiling, with trees and a building in the background.

Harvard Economist Wolfram Schlenker Is Tackling Climate Change

How extreme heat affects our land—and our food supply 

Map showing Uralic populations in Eurasia, highlighting regional distribution and historical sites.

The Origins of Europe’s Most Mysterious Languages

A small group of Siberian hunter-gatherers changed the way millions of Europeans speak today.